Larimar Therapeutics is deeply undervalued, trading at ~$3.40 despite a de-risked safety profile and a clear regulatory path ...
ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in ...
Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.
For select patients with advanced heart failure (AHF), durable left ventricular assist device (LVAD) therapy can be a life-sustaining option that improves quality of life. Since its introduction a few ...
(NEXSTAR) – For many people the holidays are a time to unwind with friends and family, but overdoing it can come with potential health risk that’s referred to as “holiday heart syndrome.” “Holiday ...
Collaboration aims to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions Rectify has developed oral, small molecules that can potentially reduce ...
(Gray News) - Thousands of bikes have been recalled for a potential brake failure issue. About 68,000 Trek- and Electra-branded bikes with coaster brakes, and replacement rear wheels with coaster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback